The EuroPCR Course Directors have chosen three major late-breaking trials to be unveiled at EuroPCR 2025. These were selected ...

With the new analysis, researchers rule out embolic protection for stroke prevention in TAVI, but not everybody has given up.

Background Acute coronary syndrome (ACS) is a global leading cause of morbidity, with residual inflammation contributing to ...

“We are excited to share significant findings from the post hoc analysis of the phase 2a clinical trial of ENV-101, highlighting our pulmonary vessel volume quantification model, Vascul8 ...

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time ...

The analysis of 3 dozen studies found similarities and differences in motivating factors for and against clinical trial ...

Pain reduction with linzagolix for uterine fibroids is partly explained by reduced heavy menstrual bleeding and fibroid ...

A UK study found that a 12-week intervention to reduce sedentary behavior was well accepted by ethnically diverse older ...

Britain’s ailing courts system now has trials scheduled to open no sooner than 2029 – almost four years away – as the ...

A new analysis found that red meat studies with industry links were more likely to report favorable results than those ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for geographic atrophy and age-related macular degeneration.